MS
PLXP

Maven Securities’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Maven Securities’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200,377
Closed -$3.87M – 1240
2021
Q3 		$3.87M Sell
200,377
-299,623
-60% -$5.24M 0.12% 118
2021
Q2 		$6.52M Buy
+500,000
New +$5.92M 0.26% 67

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

Maven Securities's PLXP Position: Q4 2021 in Review

Maven Securities sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2021, closing a stake of 200,377 shares — an estimated $3.87M sold.

Maven Securities first reported a position in PLXP in Q2 2021 and held it in 2 quarters. The position peaked at $6.52M in Q2 2021. 57 funds tracked by Wall St. Rank hold PLXP as of Q4 2021.

  • Maven Securities reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Maven Securities sold 200,377 PLx Pharma Inc. Common Stock shares in Q4 2021, an estimated $3.87M.
  • Maven Securities first reported a position in PLx Pharma Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Maven Securities's PLx Pharma Inc. Common Stock position peaked at $6.52M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2021.

Based on Maven Securities's 13F filing for Q4 2021, filed 14 Feb 2022.